Sun Pharma recalls 17,554 bottles of nasal spray from US market

22 Feb 2018 Evaluate

Sun Pharmaceutical Industries’ US arm - Sun Pharmaceutical Industries Inc (collectively Sun Pharma) is recalling over 17.5 thousand bottles of antihistamine Azelastine HCI nasal solution from the US market.  The company is recalling 17,554 bottles of Azelastine HCI Nasal Solution (Nasal Spray) 0.1 per cent (137 mcg per spray), 30 ml indicated for the treatment of the symptoms of seasonal allergic rhinitis.

The ongoing nationwide voluntary recall is a class III recall and is being recalled, following a failure to meet the %RSD requirement in the test for Droplet Size during the 6 month long term stability test station.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×